Brachytherapy: An overview for clinicians

C Chargari, E Deutsch, P Blanchard… - CA: a cancer journal …, 2019 - Wiley Online Library
Brachytherapy is a specific form of radiotherapy consisting of the precise placement of
radioactive sources directly into or next to the tumor. This technique is indicated for patients …

Current standards in the management of early and locally advanced cervical cancer: update on the benefit of neoadjuvant/adjuvant strategies

Y Zhou, E Rassy, A Coutte, S Achkar, S Espenel… - Cancers, 2022 - mdpi.com
Simple Summary Cervical cancers is a human papillomavirus infection-induced gynecologic
cancer. Due to the uneven access to prevention measures in the world, it is still a leading …

Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer

C Liu, X Li, Q Huang, M Zhang, T Lei, F Wang… - … and Targeted Therapy, 2023 - nature.com
Radiochemotherapy (RCT) is a powerful treatment for cervical cancer, which affects not only
malignant cells but also the immune and stromal compartments of the tumor. Understanding …

Radiotherapy of cervical cancer

C Chargari, K Peignaux, A Escande, S Renard… - Cancer …, 2022 - Elsevier
External beam radiotherapy and brachytherapy are major treatments in the management of
cervical cancer. For early-stage tumours with local risk factors, brachytherapy is a …

Theragnostic gadolinium-based nanoparticles safely augment X-ray radiation effects in patients with cervical cancer

C Chargari, P Maury, M Texier, C Genestie, P Morice… - ACS …, 2024 - ACS Publications
Activated guided irradiation by X-ray (AGuIX) nanoparticles are gadolinium-based agents
that have the dual benefit of mimicking the effects of a magnetic resonance imaging (MRI) …

ESGO/ESTRO quality indicators for radiation therapy of cervical cancer

C Chargari, K Tanderup, F Planchamp, L Chiva… - Radiotherapy and …, 2023 - Elsevier
Abstract Background The European Society of Gynaecological Oncology (ESGO) has
previously defined and established a list of quality indicators for the surgical treatment of …

The anti-PD-1 era of cervical cancer: achievement, opportunity, and challenge

C Li, W Cang, Y Gu, L Chen, Y Xiang - Frontiers in immunology, 2023 - frontiersin.org
Cervical cancer is one of the three major female gynecological malignancies, becoming a
major global health challenge. Although about 90% of early-stage patients can be cured by …

Evaluation of early regression index as response predictor in cervical cancer: a retrospective study on T2 and DWI MR images

D Cusumano, L Russo, B Gui, R Autorino… - Radiotherapy and …, 2022 - Elsevier
Abstract Background and Purpose Early Regression Index (ERI TCP) is an image-based
parameter based on tumor control probability modelling, that reported interesting results in …

Molecular markers to predict prognosis and treatment response in uterine cervical cancer

M Fleischmann, G Chatzikonstantinou, E Fokas… - Cancers, 2021 - mdpi.com
Simple Summary Despite the implementation of efficient screening and vaccination
programs, uterine cervical cancer remains a leading cause of cancer-related mortality in …

A risk stratification for patients with cervical cancer in stage IIIC1 of the 2018 FIGO staging system

X Liu, W Wang, K Hu, F Zhang, X Hou, J Yan… - Scientific Reports, 2020 - nature.com
This retrospective study was designed to investigate the heterogeneity of patients with
cervical cancer in stage IIIC1 (the 2018 International Federation of Gynecology and …